The medical insurance system refers to a mechanism through which a country or region addresses residents' healthcare needs by raising, allocating, and utilizing medical insurance funds in accordance with insurance principles. It serves as an effective financing mechanism for public health initiatives, represents an advanced form of social security systems, and is widely adopted globally as a healthcare cost management model.
China's basic medical security system comprises four components: the Basic Medical Insurance for Urban Employees, Basic Medical Insurance for Urban Residents, the New Rural Cooperative Medical Scheme, and the Urban-Rural Medical Assistance System. Since 1997, the government has intensified efforts to develop the medical security framework, achieving groundbreaking progress in establishing the world's largest medical insurance system. However, challenges persist due to China's vast population and regional economic disparities, including insufficient overall coverage levels, significant disparities in benefits across populations, inadequate mobility adaptation, and sustainability concerns.
Medical insurance is intrinsically linked to and interacts with healthcare services — its functions must be realized through purchasing medical services, while simultaneously driving the development of healthcare systems. On one hand, the continuous improvement of the medical insurance system provides stable funding sources for national health initiatives. These funds ultimately translate into revenue for healthcare institutions through service procurement, ensuring sustained financial support for medical development. On the other hand, as representatives of insured populations, medical insurance institutions exercise supervisory, restrictive, and guiding roles over healthcare providers during service procurement. This mechanism fosters external checks, standardizes medical service practices, and promotes healthcare system reforms and enhanced institutional management.
To support related research, CnOpenData presents China's Medical Insurance Drug Data, covering nationwide pharmaceutical information included in the medical insurance system and industrial registration details of pharmaceutical enterprises. Key fields include Drug Name (药品名称), Drug Type (药品类型), Drug Code (药品代码), Approval Number (批准文号), Enterprise Unified Social Credit Code (企业社会统一信用代码), Enterprise Registration Address (企业注册地址), and Enterprise Industry Classification (企业所属行业).
Time Coverage
As of January 31, 2023
Field Display
Sample Data
医保药品信息表
医保药品生产企业工商注册信息表
Data Update Frequency
Annual updates